MyAverix Finance
NS · Pharmaceuticals
Alpa Laboratories Ltd (ALPA)
Pharmaceuticals & Biotechnology
Alpa Laboratories Ltd (ALPA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $1.41B, P/E ratio is 9.51, net margin is 13.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ALPA
Alpa Laboratories Ltd (ALPA) — FAQ
What is Alpa Laboratories Ltd's market cap?
Alpa Laboratories Ltd (ALPA) has a reported market cap of $1.41B (data as of 2026-07-11).
What is ALPA's P/E ratio?
The price-to-earnings (P/E) ratio for Alpa Laboratories Ltd (ALPA) is 9.51 (data as of 2026-07-11).
Does Alpa Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Alpa Laboratories Ltd (ALPA). Check the MyAverix Finance app for the latest dividend data.
What sector is Alpa Laboratories Ltd in?
Alpa Laboratories Ltd (ALPA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is ALPA listed on?
ALPA is listed on NS.
What is Alpa Laboratories Ltd's net margin?
Alpa Laboratories Ltd (ALPA) reports a net margin of 13.5% (data as of 2026-07-11).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.